Life AI Net
Accueil
Archives
Calculateurs
Annuaire
Newsletter
Connexion
Français
English
简体中文
Deutsch
Français
Español
日本語
한국어
العربية
Auto
Accueil
Archives
Calculateurs
Annuaire
Newsletter
English
简体中文
Deutsch
Français
Español
日本語
한국어
العربية
Auto
Connexion
Accueil
Archives
Calculateurs
Annuaire
More
Live
Clinical OMICs
CAR T-Cell Therapy Expands Access to Kidney Transplants
Endpoints News
Alnylam to pay $30M upfront to AI startup Inceptive in RNA R&D deal
FierceBiotech
Lilly, Boehringer to slash at least $1B each from planned investments in Germany
Clinical OMICs
Genetically Raised Pulse Pressure Predisposes to Dementia-Linked Death
Clinical OMICs
Engineered Islets Could Eliminate Need for Immunosuppression in Type 1 Diabetes
FierceBiotech
Unlocking Unstructured Data with AI for Optimized Protocol Development
Endpoints News
Bristol Myers turns focus to AI costs after broad rollout to workers
Clinical OMICs
New Tumor Survival Mechanism Revealed in Aggressive ALT Cancers
Clinical OMICs
Veracyte Launches Test Identifying Breast Cancer Patients Who Don’t Need Chemo
Endpoints News
Axsome pushes back generic entry for narcolepsy drug until 2040
Clinical OMICs
Nanotube Sensor Provides Chemical Imaging for Earlier Detection of Bladder Cancer Recurrence
Endpoints News
FDA guides pharma on explaining unapproved drugs to payors
Clinical OMICs
CAR T-Cell Therapy Expands Access to Kidney Transplants
Endpoints News
Alnylam to pay $30M upfront to AI startup Inceptive in RNA R&D deal
FierceBiotech
Lilly, Boehringer to slash at least $1B each from planned investments in Germany
Clinical OMICs
Genetically Raised Pulse Pressure Predisposes to Dementia-Linked Death
Clinical OMICs
Engineered Islets Could Eliminate Need for Immunosuppression in Type 1 Diabetes
FierceBiotech
Unlocking Unstructured Data with AI for Optimized Protocol Development
Endpoints News
Bristol Myers turns focus to AI costs after broad rollout to workers
Clinical OMICs
New Tumor Survival Mechanism Revealed in Aggressive ALT Cancers
Clinical OMICs
Veracyte Launches Test Identifying Breast Cancer Patients Who Don’t Need Chemo
Endpoints News
Axsome pushes back generic entry for narcolepsy drug until 2040
Clinical OMICs
Nanotube Sensor Provides Chemical Imaging for Earlier Detection of Bladder Cancer Recurrence
Endpoints News
FDA guides pharma on explaining unapproved drugs to payors
Archives
Cet article n'est pas disponible dans les archives.